Fresenius Kabi announced the launch of Adenosine Injection, USP, 6mg/2mL and 12mg/4mL, in single-dose Simplist ready-to-administer prefilled syringes. The AP-rated product contains no preservatives.

Adenosine Injection, an endogenous nucleoside, is indicated for the conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).

Adenosine Injection Simplist prefilled syringes will be supplied in 10-count cartons. The product is also available in several vial presentations (6mg/2mL, 12mg/4mL, 60mg/20mL, 90mg/30mL).

For more information visit Fresenius-Kabi.com/US.

Related Articles

This article originally appeared on MPR